How should a patient with liver cirrhosis and a low blood urea nitrogen (≈3 mg/dL) and hyponatraemia (serum sodium 128 mmol/L) be managed?

Management of Hyponatremia (Na 128 mmol/L) with Low BUN (3 mg/dL) in Liver Cirrhosis

Stop all diuretics immediately, restrict fluid intake to 1–1.5 L per day, and administer intravenous albumin to correct the effective hypovolemia driving this hypervolemic hyponatremia. 1, 2

Immediate Actions

• Discontinue all diuretics without delay – this is the single most critical first step regardless of symptom severity 1, 2
• Restrict free water to 1–1.5 L per day to prevent further dilutional hyponatremia 1, 2
• Obtain urgent laboratory studies: serum osmolality, urine osmolality, urine sodium, and creatinine to confirm hypervolemic hyponatremia and assess renal function 2, 3
• Perform diagnostic paracentesis to rule out spontaneous bacterial peritonitis, as infection frequently precipitates hyponatremia in cirrhosis 3, 4

Understanding the Clinical Picture

The combination of BUN 3 mg/dL (extremely low) with sodium 128 mmol/L in cirrhosis signals severe hepatic synthetic dysfunction and profound effective hypovolemia despite total body volume overload. 5, 6 The low BUN reflects:

• Impaired hepatic urea synthesis from advanced liver disease 5
• Dilutional effect from massive water retention 6
• Nonosmotic ADH secretion driving free water retention 1, 6

This is hypervolemic hyponatremia – the patient has excess total body sodium AND even more excess total body water. 1, 2

Renal Function Determines Your Next Move

If Creatinine is Rising or >1.7 mg/dL (>150 µmol/L)

This indicates impending hepatorenal syndrome and mandates immediate volume expansion despite the hyponatremia. 2

• Administer 5% albumin infusion (preferred in cirrhosis) – 20–25% albumin at 6–8 g per liter if large-volume paracentesis is performed 1, 2
• Rationale: Effective hypovolemia is driving both ADH secretion and renal vasoconstriction; further water restriction alone would worsen hemodynamics and precipitate irreversible renal failure 2
• Monitor sodium every 4–6 hours during active treatment 1, 2

If Creatinine is Normal and Stable

Proceed with conservative hypervolemic hyponatremia management:

• Continue strict fluid restriction to 1–1.5 L daily 1, 2
• Limit dietary sodium to ≈90 mmol/day (≈5 g/day) – do NOT give sodium tablets, as adding sodium to a sodium-overloaded state worsens hypervolemia 2, 7
• Administer intravenous albumin (e.g., 20 g twice weekly or 5% albumin infusions) to raise oncotic pressure, mobilize interstitial fluid, and suppress ADH release 1, 2, 7
• Modify or discontinue laxatives that may contribute to electrolyte losses 1

Sodium Correction Rate – Critical Safety Ceiling

• Target 4–6 mEq/L rise per 24 hours; absolute maximum 8 mEq/L per 24 hours 1, 2, 3
• Cirrhotic patients have heightened risk of osmotic demyelination syndrome due to malnutrition, chronic hyponatremia, and alcoholism 1, 3
• Monitor serum sodium every 4–6 hours initially, then daily once stable 1, 2

When Standard Therapy Fails: Refractory Hyponatremia

If sodium remains <130 mmol/L despite 3–5 days of fluid restriction and albumin:

• Consider short-term tolvaptan (≤30 days) for symptomatic or severe hyponatremia with persistent congestion 1, 2, 8

  • Must initiate in-hospital with intensive monitoring due to risk of unpredictable rapid sodium rises 1, 2
  • Tolvaptan improved survival in cirrhotic patients who achieved sodium normalization (≥135 mEq/L) within one week 8

• Multidisciplinary evaluation involving hepatology, nephrology, and transplant surgery for: 1, 2

  • Transjugular intrahepatic portosystemic shunt (TIPS) candidacy
  • Intravenous vasoconstrictor therapy (terlipressin, midodrine, octreotide)
  • Renal replacement therapy if severe volume overload with renal failure
  • Liver transplantation evaluation – definitive treatment for refractory hyponatremia 9, 4

What NOT to Do: Common Pitfalls

• Do NOT use hypertonic (3%) saline unless the patient has severe neurologic symptoms (seizures, coma, GCS ≤8) – hypertonic saline in asymptomatic hypervolemic cirrhosis worsens ascites and edema 2, 3, 4
• Do NOT prescribe oral sodium chloride tablets – adding sodium to a sodium-overloaded state is contraindicated 7
• Do NOT continue diuretics during active hyponatremia correction – they worsen sodium loss and may precipitate acute kidney injury 2, 7
• Do NOT rely on water restriction alone in cirrhosis with ascites – this paradoxically worsens effective hypovolemia and ADH secretion without albumin support 1, 2

Monitoring Protocol

• Serum sodium: every 4–6 hours during active correction, then daily 1, 2
• Daily weight and strict intake/output charting 1, 7
• Renal function (creatinine): every 2–3 days during therapy 2, 7
• Watch for delayed osmotic demyelination signs 2–7 days after correction (dysarthria, dysphagia, altered consciousness, weakness) 1, 3

Special Consideration: Pre-Transplant Patients

If liver transplantation is anticipated within days to weeks:

• Severe hyponatremia (<120 mEq/L) markedly increases osmotic demyelination risk during intra-operative large-volume resuscitation 2, 3
• Coordinate care among nephrology, hepatology, and transplant surgery 1, 2
• Hypertonic saline may be considered if transplantation is imminent, but correction must remain ≤8 mmol/L per 24 hours 2, 3